Advanced Search

Lymphocytic Leukemia Stocks List

Symbol Grade Name % Change
BIIB C Biogen Idec Inc. 1.54
IMGN D ImmunoGen, Inc. 1.24
LGND D Ligand Pharmaceuticals Incorporated 0.52
EBS F Emergent Biosolutions, Inc. -3.32
TEVA F Teva Pharmaceutical Industries -1.65
EGRX D Eagle Pharmaceuticals, Inc. 0.59
AFMD C Affimed Therapeutics B.V. -6.86
GMAB C Genmab A/S 0.42
CLLS F Cellectis S.A. -2.73
View As Page of Charts
Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Biotechnology Cancer Drugs Monoclonal Antibodies Multiple Myeloma Clinical Trial Product Monoclonal Antibody Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Antibody Drug Conjugates Biopharmaceutical

Related ETFs - A few ETFs which own one or more of the above listed Lymphocytic Leukemia stocks.

Symbol Grade Name Weight
DWSH F AdvisorShares Dorsey Wright Short ETF 37.4
PJP C PowerShares Dynamic Pharmaceuticals 8.13
EIS A iShares MSCI Israel Capped Investable Market Index Fund 6.76
BIS C ProShares UltraShort Nasdaq Biotechnology 6.31
SBIO F ALPS Medical Breakthroughs ETF 6.07
View all Lymphocytic Leukemia related ETFs...
Compare ETFs
  • Compare DWSH to SBIO
  • Compare PJP to BIS
  • Compare PJP to SBIO

    • Recent Signals

    Date Stock Signal Type
    2021-04-20 BIIB Crossed Above 20 DMA Bullish
    2021-04-20 BIIB Crossed Above 50 DMA Bullish
    2021-04-20 BIIB 200 DMA Support Bullish
    2021-04-20 BIIB MACD Bullish Signal Line Cross Bullish
    2021-04-20 CLLS Bollinger Band Squeeze Range Contraction
    2021-04-20 CLLS Death Cross Bearish
    2021-04-20 CLLS Stochastic Reached Oversold Weakness
    2021-04-20 EBS New 52 Week Closing Low Bearish
    2021-04-20 EBS Calm After Storm Range Contraction
    2021-04-20 EBS New 52 Week Low Weakness
    2021-04-20 EGRX 20 DMA Support Bullish
    2021-04-20 EGRX Hammer Candlestick Bullish
    2021-04-20 GMAB Upper Bollinger Band Walk Strength
    2021-04-20 IMGN Stochastic Reached Oversold Weakness
    2021-04-20 LGND Bollinger Band Squeeze Range Contraction
    2021-04-20 TEVA Lower Bollinger Band Walk Weakness

    Recent News for Lymphocytic Leukemia Stocks

    Date Stock Title
    Apr 21 EBS EMERGENT BIOSOLUTIONS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Emergent BioSolutions, Inc. and Encourages Investors to Contact the Firm
    Apr 21 EBS The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LDOS, VRM and EBS
    Apr 20 EBS EMERGENT BIOSOLUTIONS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Emergent Biosolutions Inc. - EBS
    Apr 20 EBS Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Emergent BioSolutions Inc. (EBS)
    Apr 20 EBS SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS
    Apr 20 EBS EMA Finds Potential Blood Clot Link With JNJ COVID-19 Shot, Adds Safety Warning
    Apr 20 EBS Johnson & Johnson (JNJ) Q1 2021 Earnings Call Transcript
    Apr 20 EBS J&J Signals Optimism With Covid Vaccine Use in Limbo in U.S.
    Apr 20 EBS Emergent (EBS) Bayview Unit Operation on Hold for FDA Probe
    Apr 20 TEVA Is TEVA Stock A Buy or Sell?
    Apr 20 IMGN Is IMGN Stock A Buy or Sell?
    Apr 20 EBS Emergent BioSolutions CEO asked to testify on federal vaccine contracts
    Apr 20 GMAB Genmab Q1 Darzalex sales reached 1,365M
    Apr 20 GMAB Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
    Apr 20 BIIB Biogen's (NASDAQ:BIIB) Shareholders Are Down 21% On Their Shares
    Apr 20 BIIB Biogen/Eisai's lecanemab shows mixed results in mid-stage Alzheimer's Disease study
    Apr 20 AFMD Affimed's Novel Immune Engineering Approach In Oncology
    Apr 19 BIIB 18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial in Early Alzheimer's Disease Published in Peer-Reviewed Journal, Alzheimer's Research and Therapy
    Apr 19 EBS Emergent Factory Halt Adds to Obstacles for J&J’s Covid Vaccine
    Apr 19 EBS Emergent Bio hurt by second steepest drop for the year as FDA inspects manufacturing site
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
    Related Stock Lists: Chronic Lymphocytic Leukemia Medicine Lymphoma Solid Tumors Biotechnology Cancer Drugs Monoclonal Antibodies Multiple Myeloma Clinical Trial Product Monoclonal Antibody Multiple Sclerosis Pain Pharmaceutical Treatment Of Chronic Lymphocytic Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Alzheimer's Disease Antibody Drug Conjugates Biopharmaceutical

    Browse All Tags